[{"address1": "4475 Wayburne Drive", "address2": "Unit 210", "city": "Burnaby", "state": "BC", "zip": "V5G 4X4", "country": "Canada", "website": "https://filament.health", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. Its leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. The company also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, it provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.", "fullTimeEmployees": 13, "maxAge": 86400, "priceHint": 4, "previousClose": 0.03, "open": 0.03, "dayLow": 0.03, "dayHigh": 0.03, "regularMarketPreviousClose": 0.03, "regularMarketOpen": 0.03, "regularMarketDayLow": 0.03, "regularMarketDayHigh": 0.03, "beta": 1.112, "forwardPE": -0.5, "volume": 5239, "regularMarketVolume": 5239, "averageVolume": 12798, "averageVolume10days": 11304, "averageDailyVolume10Day": 11304, "bid": 0.0246, "ask": 0.045, "marketCap": 7685820, "fiftyTwoWeekLow": 0.0289, "fiftyTwoWeekHigh": 0.201, "priceToSalesTrailing12Months": 3.1643136, "fiftyDayAverage": 0.035789, "twoHundredDayAverage": 0.06895545, "currency": "USD", "enterpriseValue": 7699740, "profitMargins": -2.04835, "floatShares": 70142684, "sharesOutstanding": 256194000, "heldPercentInsiders": 0.74924004, "heldPercentInstitutions": 0.00149, "impliedSharesOutstanding": 311276000, "bookValue": 0.009, "priceToBook": 3.3333335, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -4975241, "trailingEps": -0.02, "forwardEps": -0.06, "enterpriseToRevenue": 3.17, "enterpriseToEbitda": -1.903, "52WeekChange": -0.42808217, "SandP52WeekChange": 0.26238096, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "FLHLF", "underlyingSymbol": "FLHLF", "shortName": "FILAMENT HEALTH CORP", "longName": "Filament Health Corp.", "firstTradeDateEpochUtc": 1630675800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f4c0c152-db42-327e-ac1b-3aa098825fe6", "messageBoardId": "finmb_707724980", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.03, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 872048, "totalCashPerShare": 0.004, "ebitda": -4046329, "totalDebt": 1517390, "quickRatio": 1.196, "currentRatio": 1.282, "totalRevenue": 2428906, "debtToEquity": 81.865, "revenuePerShare": 0.012, "returnOnAssets": -0.51654, "returnOnEquity": -2.5148199, "freeCashflow": -2296123, "operatingCashflow": -4373072, "grossMargins": 1.0, "ebitdaMargins": -1.66591, "operatingMargins": -2.27253, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]